These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9638863)

  • 21. Characterization of enterotoxigenic Bacteroides fragilis by a toxin-specific enzyme-linked immunosorbent assay.
    Van Tassell RL; Lyerly DM; Wilkins TD
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):578-84. PubMed ID: 8556504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD14-dependent activation of human endothelial cells by Bacteroides fragilis outer membrane.
    Sato TT; Kovacich JC; Boyle EM; Haddix TL; Weintraub A; Pohlman TH
    J Surg Res; 1998 Feb; 74(2):103-11. PubMed ID: 9587347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. News & notes: adhesiveness of Bacteroides fragilis strains isolated from feces of healthy donors, abscesses, and blood.
    Guzmàn CA; Biavasco F; Pruzzo C
    Curr Microbiol; 1997 May; 34(5):332-4. PubMed ID: 9099636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of enterotoxigenic Bacteroides fragilis strains in Poland.
    Meisel-Mikołajczyk F; Sebald M; Torbicka E; Rafałowska K; Zielińska U
    Acta Microbiol Pol; 1994; 43(3-4):389-92. PubMed ID: 7740989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Bacteroides fragilis virulence markers in vitro.
    Ferreira R; Alexandre MCF; Antunes ENF; Pinhao AT; Moraes SR; Ferreira MCS; Domingues RMCP
    J Med Microbiol; 1999 Nov; 48(11):999-1004. PubMed ID: 10535643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction of Bacteroides fragilis with components of the human fibrinolytic system.
    Ferreira Ede O; de Carvalho JB; Peixoto RJ; Lobo LA; Zingalli RB; Smith CJ; Rocha ER; Domingues RM
    FEMS Immunol Med Microbiol; 2009 Jun; 56(1):48-55. PubMed ID: 19260960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of MALDI-TOF/MS for routine detection of cfiA gene-positive Bacteroides fragilis strains.
    Fenyvesi VS; Urbán E; Bartha N; Abrók M; Kostrzewa M; Nagy E; Minárovits J; Sóki J
    Int J Antimicrob Agents; 2014 Nov; 44(5):474-5. PubMed ID: 25216544
    [No Abstract]   [Full Text] [Related]  

  • 28. Antigenic characteristics of enterotoxigenic and nonenterotoxigenic isolates of Bacteroides fragilis.
    Myers LL; Shoop DS
    Am J Vet Res; 1987 Apr; 48(4):643-5. PubMed ID: 3109288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virulence markers and antimicrobial susceptibility of bacteria of the Bacteroides fragilis group isolated from stool of children with diarrhea in São Paulo, Brazil.
    Nakano V; Avila-Campos MJ
    Mem Inst Oswaldo Cruz; 2004 May; 99(3):307-12. PubMed ID: 15273805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encapsulated strains of Bacteroides fragilis in clinical specimens.
    Lindberg AA; Berthold P; Nord CE; Weintraub A
    Med Microbiol Immunol; 1979 Mar; 167(1):29-36. PubMed ID: 440201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological detection of Bacteroides fragilis in clinical samples.
    Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
    J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of enterotoxigenic Bacteroides fragilis with bacteremia.
    Kato N; Kato H; Watanabe K; Ueno K
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S83-6. PubMed ID: 8953112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for enterotoxigenic Bacteroides fragilis in stool samples.
    Keenan JI; Aitchison A; Purcell RV; Greenlees R; Pearson JF; Frizelle FA
    Anaerobe; 2016 Aug; 40():50-3. PubMed ID: 27166180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteroides fragilis subspecies in clinical isolates.
    Polk BF; Kasper DL
    Ann Intern Med; 1977 May; 86(5):569-71. PubMed ID: 322563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence and evolution of an international cluster of MDR Bacteroides fragilis isolates.
    Sóki J; Hedberg M; Patrick S; Bálint B; Herczeg R; Nagy I; Hecht DW; Nagy E; Urbán E
    J Antimicrob Chemother; 2016 Sep; 71(9):2441-8. PubMed ID: 27246231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological study of trichloroacetic acid extracts of Bacteroides fragilis.
    Abshire RL; Dowell VR; Lombard GL
    J Clin Microbiol; 1979 Feb; 9(2):274-9. PubMed ID: 107193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological studies of Bacteroides fragilis.
    Elhag KM; Bettelheim KA; Tabaqchali S
    J Hyg (Lond); 1977 Oct; 79(2):233-41. PubMed ID: 269199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic differences within Actinobacillus pleuropneumoniae serotype 1.
    Jolie RA; Mulks MH; Thacker BJ
    Vet Microbiol; 1994 Feb; 38(4):329-49. PubMed ID: 8160348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-toxigenic pattern II and III Bacteroides fragilis strains: coexistence in the same host.
    Antunes EN; Ferreira EO; Falcão LS; Paula GR; Avelar KE; Barroso DE; Leite JP; Ferreira MC; Domingues RM
    Res Microbiol; 2004 Sep; 155(7):522-4. PubMed ID: 15313251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similarities between Fusobacterium nucleatum and bacteroides fragilis studied by two DNA probes derived from Fusobacterium nucleatum.
    Bolstad AI; Kleivdal H; Jensen HB
    Scand J Dent Res; 1994 Feb; 102(1):5-9. PubMed ID: 8153579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.